EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular Vesicles, Liposomes, and Hybrid Nanovesicles: Comparative Strategies for Targeted Cancer Therapy

Alessia Brossa iD, Michela Arena iD, Elena Ceccotti iD, Enza Di Gregorio, Giuseppe Ferrauto iD, Benedetta Bussolati iD, Stefania Bruno iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27135795 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Alessia Brossa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biotechnology and Health Science, University of Torino, 10126 Torino, Italy. Hauptthemen laut MEDLINE: Extracellular Vesicles, Liposomes, Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'università e della ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) and liposomes are nanoscale drug delivery systems extensively investigated in oncology for their ability to improve pharmacokinetics, biodistribution, and therapeutic efficacy of anticancer agents. Liposomes are clinically validated synthetic nanocarriers characterized by high versatility, scalable production, and established regulatory approval; however, their performance is limited by tumor heterogeneity, vascular barriers, adverse effects and inefficient intracellular drug release. EVs are naturally derived nanoparticles involved in intercellular communication and exhibit intrinsic biocompatibility, low immunogenicity, and biological targeting potential; yet their translation is constrained by heterogeneity, limited loading capacity, and manufacturing challenges. Different studies indicate complementary advantages between both systems, with EVs favoring biological targeting and immune modulation and liposomes enabling controlled formulation and pharmacokinetic optimization. These features have driven the development of hybrid EV–liposome nanovesicles, which integrate synthetic and biological properties to enhance tumor targeting, therapeutic efficacy, and payload diversity, including drugs, nucleic acids, and gene-editing systems. Despite promising preclinical results, challenges remain in scalability, standardization, and mechanistic understanding of in vivo behaviour. Overall, these hybrid strategies represent a promising platform for next-generation precision nanomedicine in cancer therapy and for advancing clinical translation by addressing key limitations of current delivery systems and improving therapeutic index and patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesLiposomesNeoplasmsDrug Delivery SystemsAntineoplastic AgentsNanoparticlesHumansAnimalsNanomedicine

Stichwörter der Autor:innen

cancer nanomedicinedrug delivery systemstumor targeting

Substanzen

LiposomesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Molecular Biotechnology and Health Science, University of Torino, 10126 Torino, Italy.
  • Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.
  • Department of Medical Sciences, University of Torino, 10126 Torino, Italy.

ORCID-Profile: Alessia Brossa, Michela Arena, Elena Ceccotti, Giuseppe Ferrauto, Benedetta Bussolati, Stefania Bruno

Förderung

  • Ministero dell'università e della ricerca

Zitieren

APA

Brossa, A., Arena, M., Ceccotti, E., Di Gregorio, E., Ferrauto, G., Bussolati, B., & Bruno, S. (2026). Extracellular Vesicles, Liposomes, and Hybrid Nanovesicles: Comparative Strategies for Targeted Cancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27135795

Vancouver

Brossa A, Arena M, Ceccotti E, Di Gregorio E, Ferrauto G, Bussolati B, et al. Extracellular Vesicles, Liposomes, and Hybrid Nanovesicles: Comparative Strategies for Targeted Cancer Therapy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27135795

BibTeX
@article{Brossa2026,
  author = {Brossa, Alessia and Arena, Michela and Ceccotti, Elena and Di Gregorio, Enza and Ferrauto, Giuseppe and Bussolati, Benedetta and Bruno, Stefania},
  title = {Extracellular Vesicles, Liposomes, and Hybrid Nanovesicles: Comparative Strategies for Targeted Cancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27135795}
}
Kostenlos starten →